T5	Exp 156 160	that
T6	Exp 161 179	the poor induction
T7	Exp 300 302	We
T8	Exp 310 314	that
T9	Exp 529 534	which
T10	Exp 410 430	The first alteration
T11	Exp 440 467	the constitutive expression
T12	Exp 551 591	the electrophoretic mobility shift assay
T13	Exp 723 727	that
T14	Exp 593 606	The magnitude
T15	Exp 760 769	the basis
T16	Exp 851 879	the kappa B-binding activity
T17	Exp 956 985	the NF-kappa B1 (p50) subunit
T18	Exp 1072 1076	that
T19	Exp 1119 1124	which
T20	Exp 987 1009	The second abnormality
T21	Exp 1095 1118	the Rel homology family
T22	Exp 1136 1165	the normal NF-kappa B complex
T23	Exp 1186 1218	the nucleus following activation
T24	Exp 1054 1068	these patients
T25	Exp 1414 1428	their capacity
T26	Exp 1337 1373	The altered kappa B-binding activity
R5	Coref Anaphora:T9 Antecedent:T27
R6	Coref Anaphora:T13 Antecedent:T28
R7	Coref Anaphora:T19 Antecedent:T21
R8	Coref Anaphora:T25 Antecedent:T29
T1	Protein 960 971	NF-kappa B1
T2	Protein 973 976	p50
T3	Protein 1077 1081	RelA
T4	Protein 1265 1269	RelA
T27	Exp 511 527	nuclear extracts
T28	Exp 704 722	normal individuals
T29	Exp 1377 1384	T cells
